trending Market Intelligence /marketintelligence/en/news-insights/trending/CsfsllQnD6XtaUKhFenbCw2 content esgSubNav
In This List

Oxford Immunotec starts offering for ordinary shares

Blog

Banking Essentials Newsletter 2021: December Edition

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Automating Credit Risk Surveillance Using Statistical Models

Blog

Post-webinar Q&A: Speed and Scalability – Automation in Credit Risk Modeling


Oxford Immunotec starts offering for ordinary shares

Oxford Immunotec Global PLC will sell 2.5 million ordinary shares in an underwritten public offering.

The company has granted the underwriter an option to buy up to 375,000 additional shares.

Oxford Immunotec intends to use the net proceeds from the offering for working capital and general corporate purposes.

BTIG LLC is acting as sole underwriter for the offering.